MedPath

ROTEM in Patients With Placenta Previa

Completed
Conditions
Placenta Accreta
Placenta Increta
Placenta Previa
Placenta Percreta
Interventions
Diagnostic Test: ROTEM
Registration Number
NCT04213755
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

The rotational thromboelastogram (ROTEM) test can be performed on patients with placenta previa/accreta/increta/percreta who have a high likelihood of massive bleeding, and the predictors can be identified by comparing the patients who actually show massive bleeding with those who do not.

Applying these predictive factors to pregnant women undergoing cesarean section after diagnosis of placenta previa/accreta/increta/percreta, it will be advantageous for the perioperative management because it is possible to select pregnant women with a factor of massive bleeding.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Cesarean section under spinal anesthesia
  • Placenta previa
  • Placenta accreta
  • Placenta increta
  • Placenta percreta
Exclusion Criteria
  • Coagulopathy
  • Medication with antiplatelets or anticoagulants

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patients with risks of intraoperative massive bleedingROTEMpatients with risks of intraoperative massive bleeding
Primary Outcome Measures
NameTimeMethod
Change of INTEM10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation

intrinsic pathway component

Blood loss1 min after finishing an operation

Volume of intraoperative blood loss

Change of EXTEM10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation

extrinsic pathway component

Change of APTEM10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation

fibrinolytic component

Change of FIBTEM10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation

the level of fibrinogen

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyeonggi, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath